Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
June 18, 2024
June 18, 2024
ITHACA, New York, June 18 -- Cornell University issued the following news:
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center. The new technology has the potential to improve cancer care with the very early detection of recurrence and clo . . .
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center. The new technology has the potential to improve cancer care with the very early detection of recurrence and clo . . .